MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients.
Zheng R, Yao B, Ye Y, Luo R, Wu Z, Hu X, Yuan Y, Pan X, Liu C, Huang L, Luo Y, Yang D, Shang N, Tian Y, Jia J.
Zheng R, et al. Among authors: shang n.
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):248-254. doi: 10.14715/cmb/2024.70.4.39.
Cell Mol Biol (Noisy-le-grand). 2024.
PMID: 38678596